Attention Deficit Hyperactivity Disorder Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
ADHD Clinical Trials Market Report Overview
The ADHD clinical trial market research report provides an overview of ADHD clinical trials scenario. The report provides top-line data relating to the clinical trials on ADHD. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
ADHD Clinical Trials Market Segmentation by Regions and Countries
The key regions in the ADHD clinical trials market are North America, Europe, Asia-Pacific, Middle East & Africa, and South & Central America. Most of the clinical trials were conducted in North America.
In the country wise analysis, the US has the highest number of ADHD clinical trials, as of March 2023. Canada has highest average patient enrollment of ADHD as of March 2023.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, the US has the highest proportion of ADHD to central nervous system clinical trials as of March 2023.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Brazil has the highest proportion of ADHD to central nervous system clinical trials as of March 2023.
ADHD Clinical Trials Analysis by Regions, 2023 (%)
For more regional insights into the ADHD clinical trials market, download a free report sample
ADHD Clinical Trials Market Segmentation by Sponsor Types
The key sponsor types in the ADHD clinical trials market are institution, company, and the government. Out of them, the company sponsor type dominates the market.
ADHD Clinical Trials Market Analysis by Sponsor Types, 2023 (%)
For more sponsor type insights into the ADHD clinical trials market, download a free report sample
ADHD Clinical Trials Market - Competitive Landscape
The leading sponsors in the ADHD clinical trials market are Takeda Pharmaceutical Co Ltd, Eli Lilly and Co, Johnson & Johnson, Novartis AG, Supernus Pharmaceuticals Inc, and QPS Holdings LLC among others. As of March 2023, Takeda Pharmaceutical Co Ltd sponsored the highest number of ADHD trials.
ADHD Clinical Trials Market Analysis by Sponsors, 2023 (%)
To know more about the leading players in the ADHD clinical trials market, download a free report sample
ADHD Clinical Trials Market Report Overview
Key Regions | North America, Europe, Asia-Pacific, Middle East & Africa, and South & Central America |
Key Countries | The US, China, the UK, Germany, Iran, and Japan |
Key Sponsor Types | Institution, Company, and Government |
Leading Sponsors | Takeda Pharmaceutical Co Ltd, Eli Lilly and Co, Johnson & Johnson, Novartis AG, Supernus Pharmaceuticals Inc, and QPS Holdings LLC |
ADHD Clinical Trials Regional Outlook (2023)
- Asia-Pacific
- North America
- Europe
- Middle East & Africa
- South & Central America
ADHD Clinical Trials Country Outlook (2023)
- The US
- China
- The UK
- Germany
- Iran
- Japan
ADHD Clinical Trials Sponsor Type Outlook (2023)
- Institution
- Company
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and end-point status
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) pertaining to the company
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with reasons for unaccomplishment
- The report provides enrollment trends for the past five years
- The report provides the latest news for the past three months
Reasons to Buy
- Assists in formulating key business strategies regarding investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top-level analysis of the global clinical trials market which helps in identifying key business opportunities
- Supports understanding of trial count and enrollment trends by country in the global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional, and country level
Eli Lilly and Co
Johnson & Johnson
Novartis AG
Supernus Pharmaceuticals Inc
QPS Holdings LLC
Purdue Pharma LP
Aytu BioPharma Inc
Otsuka Holdings Co Ltd
Tris Pharma Inc
Table of Contents
Table
Figures
Frequently asked questions
-
Which are the key regions in the ADHD clinical trials market?
The key regions in the ADHD clinical trials market are North America, Europe, Asia-Pacific, Middle East & Africa, and South & Central America.
-
Which are the key countries in the ADHD clinical trials market?
The key countries in the ADHD clinical trials market are the US, China, the UK, Germany, Iran, and Japan.
-
What are the key sponsor types in the ADHD clinical trials market?
The key sponsor types in the ADHD clinical trials market are institution, company, and the government.
-
Who are the leading sponsors in the ADHD clinical trials market?
The leading sponsors in the ADHD clinical trials market are Takeda Pharmaceutical Co Ltd, Eli Lilly and Co, Johnson & Johnson, Novartis AG, Supernus Pharmaceuticals Inc, and QPS Holdings LLC.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.